A Two Part, Multi-Centre, Randomized, Placebo-Controlled, Double-Blind Study of TRK-170 for the Treatment of Crohn's Disease
A Two Part, Multi-Centre, Randomized, Placebo-Controlled, Double-Blind Study of TRK-170 for the Treatment of Crohn's Disease
In Crohn's Disease Patients
Inclusion Criteria:
Exclusion Criteria:
Belgium, Belgium
Bulgaria, Bulgaria
Czech Republic, Czechia
Hungary, Hungary
Latvia, Latvia
The Netherlands, Netherlands
Norway, Norway
Poland, Poland
Romania, Romania
Serbica, Serbia
Sweden, Sweden
Ukraine, Ukraine